(3β,6α,12β)-20-(β-<SC>D</SC>-葡萄糖基吡喃糖基氧基)-3,12-二羟基达玛-24-烯-6-基 2-<I>O</I>-(6-脱氧-α-<SC>L</SC>-甘露吡喃糖基)-β-<SC>D</SC>-吡喃葡萄糖苷

产品名称：

52286-59-6
Ginsenoside Re
Chikusetsusaponin IVc
NSC 308877
Panaxoside Re
Sanchinoside Re
(3β,6α,12β)-20-(β-D-Glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl 2-O-(6-deoxy-α-L-mannopyranosyl)-β-D-glucopyranoside
Ginsenoside B2
人参皂苷Re
(3β,6α,12β)-20-(β-D-葡萄糖基吡喃糖基氧基)-3,12-二羟基达玛-24-烯-6-基 2-O-(6-脱氧-α-L-甘露吡喃糖基)-β-D-吡喃葡萄糖苷
人参皂苷B2
竹节参皂苷IVc
三七皂苷Re

产品介绍：

产品说明

一般描述

This substance is a primary reference substance with assigned absolute purity (considering chromatographic purity, water, residual solvents, inorganic impurities). The exact value can be found on the certificate. Produced by PhytoLab GmbH & Co. KG

法律信息

phyproof is a registered trademark of PhytoLab GmbH & Co. KG

基本信息

经验(实验)分子式	C₄₈H₈₂O₁₈
分子量	947.15

产品性质

等级	primary reference standard
产品线	phyproof^® Reference Substance
测定	≥95.0% (HPLC)
形式	powder
manufacturer/tradename	PhytoLab
储存温度	2-8℃
SMILES string	CC1O[C@@H](O[C@@H]2[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]2O[C@H]3C[C@]4(C)[C@H](C[C@@H](O)[C@@H]5[C@H](CC[C@@]45C)[C@](C)(CC\C=C(/C)C)O[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@@]7(C)CC[C@H](O)C(C)(C)[C@H]37)[C@H](O)[C@H](O)[C@H]1O
InChI	1S/C48H82O18/c1-21(2)11-10-14-48(9,66-42-38(60)35(57)32(54)26(19-49)63-42)23-12-16-46(7)30(23)24(51)17-28-45(6)15-13-29(52)44(4,5)40(45)25(18-47(28,46)8)62-43-39(36(58)33(55)27(20-50)64-43)65-41-37(59)34(56)31(53)22(3)61-41/h11,22-43,49-60H,10,12-20H2,1-9H3/t22-,23-,24+,25-,26+,27+,28?,29-,30+,31-,32+,33+,34+,35?,36-,37+,38+,39+,40-,41-,42-,43+,45+,46+,47+,48-/m0/s1
InChI key	PWAOOJDMFUQOKB-QVPADXGFSA-N

安全信息

象形图
警示用语：	Warning
危险声明	H302
预防措施声明	P264 - P270 - P301 + P312 - P501
危险分类	Acute Tox. 4 Oral
储存分类代码	11 - Combustible Solids
WGK	WGK 3
闪点(F)	Not applicable
闪点(C)	Not applicable